Wyss InstituteBioinformatics – Wyss Institute

From Data to Drugs: The Role of Artificial Intelligence in Drug Discovery

Jessica Leff — Thu, 09 Jan 2025 14:00:56 +0000

Code to Cure is a newsletter co-hosted by the Wyss Institute at Harvard University and Milad Alucozai on the intersection of AI, biology, and healthcare transforming medicine. By Milad Alucozai, Will Fondrie, and Megan Sperry Traditional drug discovery is slow, expensive, and prone to high clinical failure rates due to poor safety profiles, lack of efficacy, or both. Developing a new drug…

Source

From Bits to Biology: A New Era of Biological Renaissance powered by AI

Jessica Leff — Tue, 08 Oct 2024 13:00:59 +0000

Code to Cure is a newsletter co-hosted by the Wyss Institute at Harvard University and Milad Alucozai on the intersection of AI, biology, and healthcare transforming medicine. By Milad Alucozai Imagine a world where algorithms predict the next pandemic before it strikes, where you receive custom-designed treatments tailored to your individual genetic makeup, lifestyle, and medical history…

Source

Wyss Institute and Dr. Milad Alucozai Launch “Code to Cure” Newsletter

Jessica Leff — Tue, 17 Sep 2024 20:30:32 +0000

(BOSTON) – The Wyss Institute at Harvard University, along with Milad Alucozai, MSc, MPH, DrPH, is excited to announce the launch of the “Code to Cure” newsletter. Co-hosted by Alucozai and the Wyss Institute, this series will explore the convergence of artificial intelligence (AI), biology, and healthcare, highlighting the technologies and innovations shaping the future of human and planetary…

Source

Reimagining treatment for neurological diseases: Ayush Noori

Jessica Leff — Tue, 11 Jun 2024 15:09:44 +0000

By Jessica Leff Listen to Ayush tell his story | Wyss Institute · Ayush Noori Reimagine The World Ayush Noori grew up amidst a large extended family divided by geography – spread across California, Washington, and India – but united by shared core values of integrity, dedication, and resilience. At the center of this family was his grandmother, Munira Brooks, or as Ayush lovingly called…

Source

The Wyss Brain Targeting Program is expanding its “neural network”

Mariel Schoen — Wed, 24 Jan 2024 22:02:14 +0000

The Wyss Brain Targeting Program is discovering and developing new brain transport shuttles that are safe and effective, along with specially engineered mice in which drugs fused to the brain shuttles can be tested. These brain shuttles and mouse models are now available for non-exclusive licensing. The Wyss Brain Targeting Program was created as an R&D hub to promote collaboration among…

Source

Brigham-Wyss DxA

Mariel Schoen — Tue, 31 Oct 2023 18:01:32 +0000

The Wyss DxA’s clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests.

Source

Biomarker Discovery Laboratory (BDL)

Mariel Schoen — Tue, 31 Oct 2023 17:49:45 +0000

Central to the Wyss DxA’s diagnostic assay development process, and one of its organizational branches, is its Biomarker Discovery Laboratory (BDL). The development of new diagnostic tests critically hinges on the identification, quality, and accessibility of new biomarkers that unambiguously identify a disease or disorder, and upon which diagnostic assays can be built.

Source

Now, every biologist can use machine learning

Jessica Leff — Wed, 21 Jun 2023 15:57:35 +0000

By Lindsay Brownell (BOSTON) — The amount of data generated by scientists today is massive, thanks to the falling costs of sequencing technology and the increasing amount of available computing power. But parsing through all that data to uncover useful information is like searching for a molecular needle in a haystack. Machine learning (ML) and other artificial intelligence (AI) tools can…

Source

Not all statins are created equal

Jessica Leff — Tue, 09 May 2023 14:58:02 +0000

By Lindsay Brownell (BOSTON) — We’ve all recently gotten a crash-course in drug repurposing, thanks to near-daily news reports about efforts to identify existing medicines that could help treat COVID-19 in the early phase of the pandemic. A team of scientists at the Wyss Institute at Harvard University jumped into the fray in the spring of 2020, applying novel computational drug repurposing…

Source

Wearable Technology for True Movement Quantification

admin — Wed, 19 Apr 2023 20:47:43 +0000

Athletes undergoing daily training and patients undergoing physical therapy, often do not have a way to quantitatively assess their progress or obtain actionable insights that help to enhance performance or avoid injuries. There are vast options for wearable devices and activity monitors, however, those are generally limited to tracking cardiovascular activities and heart-related data.

Source